Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada
- PMID: 16757612
- PMCID: PMC1489423
- DOI: 10.1128/JCM.02563-05
Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada
Abstract
The prevalence and characteristics of PCR ribotype 027 strains of Clostridium difficile have come into question following recent outbreaks in Eastern Canada and elsewhere. In order to determine the distribution of this strain in other regions in Canada, we screened a bank of 1,419 isolates recovered from three different Canadian health regions between 2000 and 2004. Among isolates from a Montreal area hospital, PCR ribotype 027 strains represented 115/153 strains (75.2%) from 2003 to 2004, but ribotype 027 strains were absent in 2000 and 2001. In Calgary, by contrast, ribotype 027 rates have remained relatively stable over 4 years of surveillance, representing 51/685 (7.4%) hospital isolates and 62/373 (16.6%) strains from the community (P < 0.001). PCR ribotype 027 accounted for 8/135 (5.9%) hospital isolates in the Fraser Health Region in 2004. repetitive extragenic palindromic PCR was used to subtype a random selection of 027 isolates from each region. All 10 of the isolates from Quebec were of a single subtype, which was also dominant among isolates from Alberta (8/10 isolates) and British Columbia (6/8 isolates). Comparative sequencing of the tcdC repressor gene confirmed the documented 18-bp deletion and identified a second, single-base-pair deletion at position 117. Both deletions were conserved across all three provinces and were identified in a United Kingdom reference strain. The presence of a frameshift in the early portion of the tcdC gene implies serious functional disruption and may contribute to the hypervirulence of the 027 phenotype. PCR ribotype 027 strains appear to be widely distributed, to predate the Montreal outbreak, and to have measurable community presence in Western Canada.
Figures



Similar articles
-
[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. Epub 2008 Oct 7. Pathol Biol (Paris). 2008. PMID: 18842360 French.
-
Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing.Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S13-8. doi: 10.1016/S0924-8579(09)70010-X. Int J Antimicrob Agents. 2009. PMID: 19303562
-
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands.Clin Infect Dis. 2007 Sep 15;45(6):695-703. doi: 10.1086/520984. Epub 2007 Aug 6. Clin Infect Dis. 2007. PMID: 17712752
-
[Dramatic increase of Clostridium difficile-associated diarrhea in Germany: has the new strain PCR-ribotype 027 already reached us?].Dtsch Med Wochenschr. 2007 Feb 2;132(5):223-8. doi: 10.1055/s-2007-959314. Dtsch Med Wochenschr. 2007. PMID: 17252365 Review. German. No abstract available.
-
Reprint of New opportunities for improved ribotyping of C. difficile clinical isolates by exploring their genomes.J Microbiol Methods. 2013 Dec;95(3):425-40. doi: 10.1016/j.mimet.2013.09.009. Epub 2013 Sep 16. J Microbiol Methods. 2013. PMID: 24050948 Review.
Cited by
-
The changing epidemiology of Clostridium difficile infections.Clin Microbiol Rev. 2010 Jul;23(3):529-49. doi: 10.1128/CMR.00082-09. Clin Microbiol Rev. 2010. PMID: 20610822 Free PMC article. Review.
-
Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.Lancet Infect Dis. 2010 Jun;10(6):395-404. doi: 10.1016/S1473-3099(10)70080-3. Lancet Infect Dis. 2010. PMID: 20510280 Free PMC article. Review.
-
Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.J Clin Microbiol. 2009 Jul;47(7):2142-8. doi: 10.1128/JCM.02498-08. Epub 2009 Apr 29. J Clin Microbiol. 2009. PMID: 19403775 Free PMC article.
-
Clostridium difficile infection: molecular pathogenesis and novel therapeutics.Expert Rev Anti Infect Ther. 2014 Jan;12(1):131-50. doi: 10.1586/14787210.2014.866515. Expert Rev Anti Infect Ther. 2014. PMID: 24410618 Free PMC article. Review.
-
Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms.PLoS One. 2013;8(2):e56545. doi: 10.1371/journal.pone.0056545. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437164 Free PMC article.
References
-
- Alonso, R., A. Martin, T. Pelaez, M. Marin, M. Rodriguez-Creixems, and E. Bouza. 2005. An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile. J. Med. Microbiol. 54:155-157. - PubMed
-
- Cohen, S. H., Y. J. Tang, and J. Silva, Jr. 2000. Analysis of the pathogenicity locus in Clostridium difficile strains. J. Infect. Dis. 181:659-663. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases